Biogen (BIIB) had the highest return in Q4 1995 by a US stock in the S&P 500 (GSPC), returning 1,268.5%.
| ASSET | QUARTER | % RETURN |
|---|---|---|
Biogen (BIIB) | Q4 1995 | 1,268.53% |
NetApp (NTAP) | Q4 1995 | 95.72% |
Hologic (HOLX) | Q4 1995 | 78.26% |
Intuit (INTU) | Q4 1995 | 65.96% |
TJX Companies (TJX) | Q4 1995 | 60.55% |
Cadence Design Systems (CDNS) | Q4 1995 | 58.49% |
DaVita HealthCare Partners (DVA) | Q4 1995 | 47.24% |
Gilead Sciences (GILD) | Q4 1995 | 45.47% |
Gartner (IT) | Q4 1995 | 43.98% |
Vertex Pharmaceuticals (VRTX) | Q4 1995 | 42.32% |
Humana (HUM) | Q4 1995 | 36.03% |
UnitedHealth (UNH) | Q4 1995 | 35.14% |
Deere (DE) | Q4 1995 | 30.7% |
Universal Health Services (UHS) | Q4 1995 | 30.04% |
Henry Schein (HSIC) | Q4 1995 | 29.67% |
Zebra Technologies (ZBRA) | Q4 1995 | 28.91% |
Mosaic (MOS) | Q4 1995 | 28.86% |
Fifth Third Bancorp (FITB) | Q4 1995 | 28.63% |
Erie Indemnity (ERIE) | Q4 1995 | 28.55% |
Nucor (NUE) | Q4 1995 | 27.82% |
LIN TV (LIN) | Q4 1995 | 27.24% |
Kimberly-Clark (KMB) | Q4 1995 | 27.15% |
Eli Lilly and (LLY) | Q4 1995 | 26.94% |
CoreSite Realty (COR) | Q4 1995 | 26.92% |
IDEXX Laboratories (IDXX) | Q4 1995 | 26.21% |
